FDA-compliant Transporter Studies at SOLVO Biotechnology

SOLVO Biotechnology

provides all the definitive in-vitro P-gp assays that comply with the 2006 FDA Draft Guidance on assessing drug-drug interactions
has the widest range of transporter assay systems that satisfies all the upcoming FDA requirements for efflux and uptake transporters
has unparalleled knowledge on transporters, and has the biggest drug transporter R&Đ department publishing regularly in peer-reviewed journals
was the first CRO to recognize the importance of studying various drug transporters individually
continuously expands its portfolio based on the latest results in transporter science, the needs of the pharmaceutical industry and the various regulatory agencies such as FDA and EMEA

Why is P-gp important?

P-gp drug efflux transporter is present in all pharmacological barriers influencing the ADMETox properties of drugs
drugs that are substrates or inhibitors of P-gp may participate in drug-drug or drug-nutrient interactions, leading to modified bioavailability of the drug and to serious side effects such as morbidity in case of drugs with narrow therapeutic index

What are the main characteristics of SOLVO's FDA-compliant P-gp PREDISCREEN^TM services?

studies can be conducted using human Caco-2, or MDR1-MDCKII cell lines according to your request
the general protocol applies two P-gp inhibitors in the Caco-2 assay recommended by the FDA: Verapamil and Ketoconazole
it can identify P-gp substrate and inhibitory properties of your NCE, IND or NDA
it can provide IC₅₀ data for the inhibition of digoxin transport
it is a flexible design for optimal cost and quick turn-around time
a clear and consistent flow-chart with decision points describes SOLVO's FDA-compliant P-gp studies

SOLVO Biotechnology is the right choice for P-gp-related studies!

SOLVO has the most comprehensive P-gp technology platform from HT in-vitro assays to in-vivo studies
- in-vitro assays
  - P-gp PREDIVEZ^TM Kit: this vesicular transport assay is a unique HT SOLVO technology that identifies all the compounds that interact with P-gp
  - P-gp PREDEASY^TM Kit: SOLVO's HT ATPase assay is able to distinguish substrates and inhibitors
  - P-gp Calcein assay: SOLVO's proprietary cellular dye efflux assay
  - Caco-2 monolayer assays are available at different levels of complexity: basic, custom and FDA setup. Transporter specific interactions can also be investigated with the use of P-gp and BCRP substrates and inhibitors
  - MDR1-MDCKII monolayer assays
- in-vivo services
  - rat brain microdialysis uses quinidine as reporter substrate, and PSC833 as a specific P-gp inhibitor
SOLVO suggest tailor-made solutions to optimize study design and the right combination of the appropriate assays
you can save money and time by choosing the most appropriate SOLVO P-gp assays for the different stages of your drug development

Which additional drug transporters are under FDA consideration?

Efflux transporters: BCRP, BSEP
Uptake transporters: OATP1B1, OATP2B1, OATP1B3, NTCP, OCT2, OAT1, OAT3

Products and PREDISCREEN^TM service solutions for these transporters:

BCRP: BCRP-MDCKII monolayer assay, Caco-2 monolayer assay with BCRP inhibitor, BCRP-PREDEASY^TM Kit, BCRP-PREDIVEZ^TM Kit, BCRP cellular dye efflux assay (Hoechst 33342), double-transfectant OATP2B1/BCRP-MDCKII monolayer assay, rat liver perfusion, rat brain microdialysis
stably transfected uptake transporter cell lines: OATP1B1, OATP2B1, OATP1B3, NTCP, OCT2, OAT1, OAT3
BSEP: vesicular transport assay
OATP1B1: cellular assay
OATP2B1: cellular assay
OATP1B3: cellular assay
NTCP: cellular assay
OCT2: cellular assay
OAT1: cellular assay
OAT3: cellular assay

For additional information please contact SOLVO at FDAcompliance@solvo.com or follow the following links:

SOLVO Product and PrediScreen service catalogue
Utilization of SOLVO products and services in the drug development pipeline
SOLVO membrane transporter solutions according to the Biopharmaceutics Drug Disposition Classification System (BDDCS)

With our best regards,
SOLVO Biotechnology
Business Development Team

CONTACT INFORMATION:

SOLVO Biotechnology
2 Gyár St. H-2040 Budaörs, HUNGARY
E-mail: sales@solvo.com
web: www.solvo.com
Phone: +36-23/503-940
Fax: +36-23/503-941

SOLVO distributors:
in US and Canada: XenoTech LLC www.xenotechllc.com,
in Europe: SOLVO and Tebu-bio www.tebu-bio.com,
in Japan: Nosan www.nosan.co.jp,
in India: Krishgen www.krishgen.com

Privileged/confidential information may be contained in this message. This communication is confidential and intended solely for the addressee(s). Unauthorized distribution, modification or disclosure of the contents may be unlawful. If you receive this in error, please notify the sender and delete it from your system. If you are not the addressee indicated in this message (or responsible for delivery of the message to such person), you may not copy or deliver this message to anyone.

If you wish to unsubscribe, please send a letter to

with 'unsubscribe' in the subject field.